Microway Boosts Solutions with 2nd Generation Intel Xeon Scalable Processors

PLYMOUTH, MA, US - May 29, 2019 -  Microway, a leading provider of computational clusters, servers, and workstations for AI and HPC applications, announces that bleeding-edge 2nd Generation Intel®  Xeon® Scalable processors (“Cascade Lake-SP”) are now shipping in volume across all Microway Xeon offerings, including next-generation NumberSmasher™ clusters, servers, and WhisperStations

BioIVT Named Service Provider for Promega Immunotherapy Bioassays

WESTBURY, NY - May 29, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will now offer Promega Immune Checkpoint and antibody-dependent cell-mediated cytotoxicity (ADCC) Reporter Bioassays to support immunology and immuno-oncology research

BOC Sciences Continues to Broaden Its Inhibitor Range for Researchers

SHIRLEY, NY, UNITED STATES - May 29, 2019 - As one of the world's leading chemical suppliers, BOC Sciences announces to continuously broaden its small molecule inhibitor range in response to an increasingly urgent need to find a cure for some major diseases that are inflicting the human beings

Creative Proteomics Has Announced a Wide Range of Newly-developed Protein Identification Services and Peptides Analysis Services

SHIRLEY, NY - May 29, 2019 - SHIRLEY, NY – May 29, 2019 - Creative Proteomics, a leading supplier in metabolomics services, has recently upgraded its protein identification and peptides analysis services to researchers

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference

PITTSBURGH, PA, UNITED STATES - May 24, 2019 - Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida

Certara Introduces Integral, its Next-generation Data Repository

PRINCETON, NJ - May 28, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the introduction of Certara Integral™, its next-generation data repository for collecting, managing, and storing multiple types of data sets for analysis, sharing and reporting of clinical pharmacology, pharmacometrics and other relevant clinical data

Reprieve Cardiovascular Announces Late-Breaking Acute Heart Failure Clinical Trial Data

MILFORD, MA, US - May 25, 2019 -

• TARGET-1 and TARGET-2 trials: safe decongestion using first fully automated fluid management system 
• Significant increase in diuresis, net negative fluid balance, improvement of kidney function and improvement in clinical symptoms
• Significant drop in CVP while systolic BP remained stable

Creative Diagnostics Launches IHC/Pathology Antibodies for Research

SHIRLEY, NY, UNITED STATES - May 28, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announced it has launched a series of IHC/Pathology antibodies for research use

CanDIG to be part of new Canadian Digital Health and Discovery Platform

MONTRÉAL, QC, CANADA - May 27, 2019 - Today, Minister Navdeep Bains announced funding for the Digital Health and Discovery Platform (DHDP) through the health and biosciences stream of the Strategic Innovation Fund

Creative Proteomics Upgrades a Wide Range of Newly-developed Protein Identification Services and Peptides Analysis Services

SHIRLEY, NY - May 25, 2019 - SHIRLEY, NY – May 25, 2019 - Creative Proteomics, a leading supplier in metabolomics services, has recently upgraded its protein identification and peptides analysis services to researchers

Cala Health Raises $50 Million Series C Funding

BURLINGAME, CA, UNITED STATES - May 21, 2019 - Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today announced it has completed a $50 million Series C financing

PROMINENT TECHNOLOGIST WILLIAM F. (BILL) STASIOR JOINS AVELLINO LABS EXECUTIVE ADVISORY COMMITTEE

MENLO PARK, CA - May 23, 2019 - Avellino Labs, global biotechnology and genetic science innovators, announced today the addition of William F

TTS Pharma Limited announces closing of £10.3 million fundraising and new board appointment

LONDON AND LIVERPOOL, UK - May 23, 2019 -

• The completion of series B fundraise of £10.3 million
• The appointment of Paul Atherton as Chairman

CD Genomics Announces Highly Accurate and Sensitive Genome Sequencing Services for Conducting a Genome-wide Analysis

SHIRLEY, NY, UNITED STATES - May 22, 2019 - SHIRLEY, NY, UNITED STATES – May 23, 2019 - CD Genomics, an expert in transcriptomics and next generation sequencing company, announces the technical escalation of its sequencing services, The updated or newly-developed service ranges include three: nanopore sequencing, mitochondrial genome sequencing, and whole plasmid sequencing, which are based on some of the most powerful platforms in this field with unrivaled accuracy and sensitivity

Central Pharma partners with Veratrak to digitise supply chain operations

LONDON, UK - May 22, 2019 - Veratrak, a UK-based software provider dedicated to transforming supply chains across the life science industry, has announced that contract packaging organisation (CPO) Central Pharma has selected its platform to help it achieve digitised end-to-end visibility of its supply chain and improve collaboration

Creative Biolabs Scholarship Worth $1,000 Available to Global College Students

SHIRLEY, NY - May 22, 2019 - Creative Biolabs, a leading custom service provider in antibody production and engineering, launched its annual scholarship program, intended to subsidize worldwide college students with their research or further education in the biology or chemistry related fields

Mercia invests £2.0 million in transdermal drug delivery specialist, Medherant

COVENTRY, UK - May 21, 2019 - Medherant Limited (“Medherant”), the clinical-stage developer of innovative transdermal delivery products for pain and CNS diseases using its unique TEPI Patch® technology, has today announced a new £2 million investment

UKI2S and Innovate UK launch new £10m initiative to accelerate growth of early stage science and engineering companies

LONDON, UK - May 21, 2019 - The £27m UK Innovation & Science Seed Fund (UKI2S) and Innovate UK (IUK) have launched a joint initiative, the UKI2S Innovate Accelerator

WCG to Lead Educational Session on Implementing the Revised Common Rule at AAHRPP Annual Conference

PRINCETON, NJ - May 20, 2019 - The WIRB-Copernicus Group® (WCG™) announced today that David Borasky, MPH, CIP, its vice president, IRB Compliance will be leading an educational session on the revised Common Rule at the Association for the Accreditation of Human Research Protection Programs, Inc

Wasdell Group strengthens offering with Honeywood acquisition

- May 20, 2019 - The Wasdell Group (Wasdell), a leading outsourcing partner for companies in the pharmaceutical industry, has announced its acquisition of Honeywood Limited, a specialist manufacturer and packager located in Northampton, UK